CANCER RESEARCH HORIZONS
Cancer Research Horizons develops and commercialises exciting new discoveries in cancer research. They’re the meeting point between academia and industry. Their deep understanding of both perspectives enables them to translate promising research into commercial propositions for the greatest patient benefit and maximum financial return. CRT is uniquely placed to capitalise on the research and connections of theirr parent organisation Cancer Research UK, the world’s largest charitable funder... of cancer research and the strong links they’ve established with leading clinical and academic institutions, pharmaceutical companies and biotechs worldwide. CRT has 30 years’ specialist experience in the commercialisation of cancer research and a proven track record of successful innovation. CRT personnel are experienced, dedicated and highly motivated with an average length of service of nearly 6 years. The workforce is split between drug discovery and commercialisation for a comprehensive approach to getting breakthrough therapeutics to patients.
CANCER RESEARCH HORIZONS
Industry:
Biotechnology Clinical Trials Health Diagnostics Medical
Founded:
2002-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cancerresearchhorizons.com
Total Employee:
101+
Status:
Active
Contact:
(203) 469-6300
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Amazon Ireland Region Drupal 7 IOMart DNS
Similar Organizations
FSI Central Research of Epidemiology
FSI central research of epidemiology develops reagents on infections.
Current Advisors List
Board_member
2011-10-01
Current Employees Featured
Raj Mehta Team Member @ Cancer Research Horizons
Team Member
Deborah Harland Non Executive Director @ Cancer Research Horizons
Non Executive Director
2015-11-01
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-01 | BioCaptiva | Cancer Research Horizons investment in Seed Round - BioCaptiva | 2.1 M GBP |
| 2016-09-28 | Achilles Therapeutics | Cancer Research Horizons investment in Seed Round - Achilles Therapeutics | 13.2 M GBP |
| 2016-09-16 | GammaDelta Therapeutics | Cancer Research Horizons investment in Seed Round - GammaDelta Therapeutics | N/A |
Newest Events participated
Participated in Biotech and Money London
on 2017-02-07 as sponsor
Official Site Inspections
http://www.cancerresearchhorizons.com Semrush global rank: 2.62 M Semrush visits lastest month: 6.61 K
- Host name: 104.21.48.1
- IP address: 104.21.48.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cancer Research Horizons"
About us - Cancer Research Horizons
By uniting our in-house drug discovery and development expertise and Cancer Research UK's network of researchers and clinicians with cutting-edge technology, partners and investment, …See details»
Our reports and corporate responsibility | Cancer Research Horizons
Governance responsibility: We will commit to open and transparent auditing and reporting, and ensure continued alignment of our work with patient benefit. Environmental responsibility: We …See details»
Cancer Research Horizons - Crunchbase Company …
The organization offers various innovations for licensing and co-development, including novel compounds and databases for cancer research. …See details»
Cancer Research Horizons | LinkedIn
Cancer Research Horizons is Cancer Research UK's innovation engine. We take scientific breakthroughs from the lab bench to the bedside, translating them into effective treatments …See details»
Cancer Research Horizons - Nature
CancerResearchHorizons London,UK Tel: +44 20 3469 6653 Email:andrea.schievella@cancer.org.uk GeorgeTzircotis,AssociateDirector …See details»
Cancer Research Horizons: partnering bold ideas to conquer …
The organization already has an impressive track record across all stages of drug and diagnostic development: Cancer Research Horizons is among the world’s largest oncology out-licensors, …See details»
Introduction - Annual Review 2022-23 - Cancer …
Welcome to the 2022/23 annual review for Cancer Research Horizons, the innovation arm of Cancer Research UK. Cancer Research Horizons comprises extensive commercialisation and drug discovery expertise and platforms to …See details»
Cancer Research Horizons - Innovate UK Business Connect
Cancerresearchhorizons.com . Share this project. Our CRH Seed Fund (launched June 2022) builds on over 25 years of CRH establishing and growing successful companies (\>60 …See details»
Cancer Research Horizons Investor Profile: Portfolio
Dec 22, 2023 Information on investments, active portfolio, exits, fund performance, dry powder, and co-investors for Cancer Research Horizons. Use the PitchBook Platform to explore the full profile.See details»
Our people - Cancer Research Horizons
Our teams offer the full spectrum of translational expertise, from target assessment and validation, drug discovery, pre-clinical and clinical capabilities and translational funding to licensing, …See details»
HowCRUK’sbiotech-likegroupisaccelerating clinical development …
Its parent organization to speed-up the discovery and development of transformative oncology ... CancerResearchHorizons London,UK Tel: +44 20 3469 6608 …See details»
Deep Science Ventures and Cancer Research Horizons Amp Up …
Jul 26, 2022 For more information and to get in touch with the team, visit cancerresearchhorizons.com; About Cancer Research UK . Cancer Research UK is the …See details»
Predictive Oncology and Cancer Research Horizons have
Mar 17, 2023 For more information and to get in touch with the team, visit cancerresearchhorizons.com. Contacts Predictive Oncology Theresa Ferguson 1 630 566 2003See details»
Partners - Cancer Research Horizons
“We are thrilled about entering this alliance with a very like-minded organization such as Cancer Research UK. The combination of excellent science and proactive valorization makes …See details»
Cancer Research Horizons : Quotes, Address, Contact - News …
6 days ago Cancer Research Horizons is Cancer Research UK's new innovation engine. We take scientific breakthroughs from the lab bench to the bedside, translating them into effective …See details»
Our impact - Annual Review 2022-23 - Cancer Research Horizons
Cancer Research Horizons exists to ensure that new discoveries and insights from research ultimately end up helping people with cancer. In this section, we provide some examples of …See details»
Cancer Research Horizons: Driving Innovation and Strengthening …
May 20, 2022 In April 2022, Cancer Research UK unveiled Cancer Research Horizons, its new approach to driving innovation in the field. Technology Networks had the opportunity to speak …See details»
Our portfolio - Cancer Research Horizons
TechBio company PentaBind is using generative AI to develop aptamers that could target previously undruggable human proteins. "Our AI-driven technology streamlines the …See details»
Researchers | Cancer Research Horizons
We offer support wherever you are in the translational pathway. Whether you're looking for access to drug discovery expertise and tools, just starting out with an innovative idea and want to …See details»